Abstract:Key PointsRecently, arrays of clustered, regularly interspaced short palindromic repeats (CRISPRs) have been implicated in a novel genetic interference pathway that limits phage infection and plasmid conjugation. CRISPR loci keep a record of past infections to provide bacteria and archaea with a 'genetic memory' that directs the rejection of invader DNA molecules; therefore these loci constitute an adaptive immune system.CRISPRs (which are approximately 25–50 nucleotides long) are separated by similarly short sequences called spacers that match bacteriophage or plasmid sequences and specify the targets of interference. CRISPR-associated (cas) genes, a set of conserved genes that are associated with these loci, are usually present on one or the other side of the array.CRISPR loci are transcribed as a long precursor that is processed by Cas proteins within the repeat sequences to generate small CRISPR RNAs (crRNAs). The crRNAs serve as guides for target recognition during CRISPR interference. crRNA–Cas ribonucleoprotein complexes seem to generally target invading DNA sequences during interference but may also target RNAs in some species.Upon bacteriophage challenge of a CRISPR-containing bacterial population, mutants resistant to the infection arise through the incorporation of additional spacer sequences derived from the challenging phage. This allows the bacteria to evolve rapidly and adapt to the viruses in the environment.Bacteriophages and plasmids can mobilize foreign genetic material between cells, a process known as horizontal gene transfer (HGT), which is a fundamental source of genetic variability for the evolution of bacteria and archaea. CRISPR interference prevents phage infection and plasmid conjugation and therefore constitutes a natural barrier to HGT. In addition, bacteriophages constantly mutate to evade CRISPR defence. Therefore, CRISPR interference has an important role in the evolution of microbial communities.

CRISPR-Cas adaptation in Escherichia coli

CRISPR-Cas: Adapting to change

CRISPR-Cas immunity in prokaryotes

Cas1-Cas2 physically and functionally interacts with DnaK to modulate CRISPR Adaptation

Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

Host nucleases generate prespacers for primed adaptation in the E. coli type I-E CRISPR-Cas system

CRISPR-Cas: biology, mechanisms and relevance

CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea

CRISPR/Cas, the Immune System of Bacteria and Archaea

Processing and integration of functionally oriented prespacers in the Escherichia coli CRISPR system depends on bacterial host exonucleases

Highly active CRISPR-adaptation proteins revealed by a robust enrichment technology

CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures

CRISPR-Cas systems: role in cellular processes beyond adaptive immunity

The Biology of CRISPR-Cas: Backward and Forward

CRISPR adaptation in can be driven by phage environmental DNA

SspA is a transcriptional regulator of CRISPR adaptation in E. coli

Exploiting CRISPR/Cas: Interference Mechanisms and Applications

How the other half lives: CRISPR-Cas's influence on bacteriophages

CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes